Intermittent Mechanical Compression For Peripheral Arterial Disease
NCT ID: NCT00855673
Last Updated: 2009-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
30 participants
INTERVENTIONAL
2001-01-31
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Major endpoints are improved exercise tolerance and relevant blood pressure ratios
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)
NCT00146666
Open Label Clinical Study to Assess the Clinical Safety of a New Compression Device in Subjects With Peripheral Arterial Vascular Disease
NCT00854516
Feasibility of Outpatient Care After Manual Compression in Patients Treated for Peripheral Arterial Disease by Endovascular Technique With 5F Sheath Femoral Approach
NCT03185052
Safety and Efficacy Study of a New Intermittent Pneumatic Compression Device to Treat Patients With Peripheral Arterial Disease (PAD) Stage II
NCT00762086
Evaluation of Compression Therapy in Patients With Mild to Moderate PAD or Diabetes Mellitus
NCT03384758
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active
Active group receiving intermittent compression
Intermittent Mechanical Compression
FM220 device
Control
Standard Medical Treatment
Control
Standard medical treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intermittent Mechanical Compression
FM220 device
Control
Standard medical treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* resting ABI in the affected limb \<0.8
Exclusion Criteria
50 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Universitario Getafe
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hospital Universitario Getafe
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joaquin DeHaro, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital Universitario Getafe
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FM-S1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.